National Precursor Log Exchange (NPLEx™)/ MethCheck by Appriss® Health
Provides pharmacies the tools to track pseudoephedrine (PSE) purchases and ensure compliance by collecting and uploading signatures via the signature capture pad for PSE purchases. NPLEx/MethCheck works with QS/1’s Point-of-Sale and complies with federal, state and local laws governing the purchase, sale and reporting of PSE items.
For more information, or to enroll, email email@example.com or call 800.845.7558, ext., 1471.
Offers the Architext Graphic Library (AGL) that is fully integrated with QS/1’s systems to provide a current warning label service. It prints warning labels and prescription bottle labels to save time and improve workflow. Seventeen languages are available, and the service does not require additional hardware.
QS/1 Prescription Monitoring Program (PMP)
QS/1’s PMP extracts controlled-substance prescription information from pharmacies’ PowerLine™ claims or the Rx Monitoring Log and submits it to the state agency within the required time frame to ensure pharmacies are compliant with state laws. This eliminates the need for staff to manually report to the state agency. Pharmacies are assigned an iManager account, and if the state provides error reports to QS/1, pharmacies can use iManager to review that information and the claims submitted. PMP currently reports for 46 states.
Medicare Part B Compliance Documentation
Enables NRx® and PrimeCare®pharmacies to serve Part B customers and print CMS Medicare Part B required documentation, including Medicare Supplier Standards, Assignment of Benefits, Proof of Delivery and item-specific Physician Orders. For more information, including set-up instructions, visit www.qs1support.com and select Service Documents, Medicare Part B Compliance Documentation for Pharmacy. Once enrolled, setup is completed by the QS/1 Training Department.
Appriss Health’s NarxCare™
Appriss Health’s NarxCare PMP Analysis (formerly NARxCHECK) is a patented analytics tool and care management platform that analyzes controlled substance data from Prescription Monitoring Programs (PMPs) and provides easy-to-use insights into patients’ controlled substance prescription histories. Authorized prescribers and dispensers can easily access PMP data and NarxCare analytics within their own workflow, and decisions can be based on objective insights into potential drug misuse or abuse, ultimately leading to improved patient safety.
To enroll: visit apprisshealth.com.
MedGuides® powered by PDR® by ConnectiveRx
Prints federally mandated MedGuides at no charge for customers enrolled with CarePoints. PDR’s MedGuides are formatted to be about one half the size of the FDA version saving resources for the stores.